Abbott

Abbott Laboratories said it could resume infant formula production within two weeks at a Michigan manufacturing plant that has been shut since February because of bacterial contamination concerns, exacerbating a nationwide formula shortage. The Illinois-based company said Wednesday it would resume production pending approval from the Food and Drug Administration, which has been conducting an investigation into whether bacterial contamination at the plant…